Amneal Pharmaceuticals Stock Quote AMRX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

7.96

Bid

7.45

Ask

7.96

Volume

108

0.00 Day's Range 0.00

6.29 52 Week Range 9.475

Market Cap

2.495B

Previous Close

7.96

Open

Last Trade

7.77

Last Trade Time

08:00:01

Financial Volume

VWAP

Average Volume (3m)

1,877,537

Shares Outstanding

313,419,599

Dividend Yield

PE Ratio

-15.74

Earnings Per Share (EPS)

-0.37

Revenue

2.79B

Net Profit

-116.89M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.amneal.com

Headquarters

Wilmington, Delaware, USA

Founded

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was $7.96. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of $ 6.29 to $ 9.475.

Amneal Pharmaceuticals currently has 313,419,599 shares outstanding. The market capitalization of Amneal Pharmaceuticals is $2.49 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -15.74.

Form 4 - Statement of changes in beneficial ownership of securities

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension

Key complex product approval in the Affordable Medicines segment this yearCommercial launch planned for third...

Amneal to Participate at Upcoming Investor Conferences in June

BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will...

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

Brekiya® becomes the first and only DHE autoinjector that allows patients to self-administer the same...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.7	9.64187327824	7.26	8.0489	7.26	1928952	7.75687694	CS
4	0.47	6.27503337784	7.49	8.0489	7.02	1578484	7.46174202	CS
12	-0.92	-10.3603603604	8.88	9	6.685	1877537	7.56647907	CS
26	0.035	0.441640378549	7.925	9.16	6.685	1636761	7.92193394	CS
52	0.86	12.1126760563	7.1	9.475	6.29	1439710	7.91586773	CS
156	2.08	35.3741496599	5.88	9.475	5.01	1463399	7.27238367	CS
260	2.08	35.3741496599	5.88	9.475	5.01	1463399	7.27238367	CS

AMRX - Frequently Asked Questions (FAQ)

What is the current Amneal Pharmaceuticals share price?

The current share price of Amneal Pharmaceuticals is $ 7.96

How many Amneal Pharmaceuticals shares are in issue?

Amneal Pharmaceuticals has 313,419,599 shares in issue

What is the market cap of Amneal Pharmaceuticals?

The market capitalisation of Amneal Pharmaceuticals is USD 2.49B

What is the 1 year trading range for Amneal Pharmaceuticals share price?

Amneal Pharmaceuticals has traded in the range of $ 6.29 to $ 9.475 during the past year

What is the PE ratio of Amneal Pharmaceuticals?

The price to earnings ratio of Amneal Pharmaceuticals is -15.74

What is the cash to sales ratio of Amneal Pharmaceuticals?

The cash to sales ratio of Amneal Pharmaceuticals is 0.66

What is the reporting currency for Amneal Pharmaceuticals?

Amneal Pharmaceuticals reports financial results in USD

What is the latest annual turnover for Amneal Pharmaceuticals?

The latest annual turnover of Amneal Pharmaceuticals is USD 2.79B

What is the latest annual profit for Amneal Pharmaceuticals?

The latest annual profit of Amneal Pharmaceuticals is USD -116.89M

What is the registered address of Amneal Pharmaceuticals?

The registered address for Amneal Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Amneal Pharmaceuticals website address?

The website address for Amneal Pharmaceuticals is www.amneal.com

Which industry sector does Amneal Pharmaceuticals operate in?

Amneal Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
RBNERobin Energy Ltd	$ 10.54 (214.63%)	19.39M
LGHLWLion Group Holding Ltd	$ 0.0044 (83.33%)	27.5k
USEGUS Energy Corp	$ 2.46 (73.24%)	43.42M
ICONIcon Energy Corporation	$ 2.91 (62.57%)	20.36M
ANNAAleAnna Inc	$ 13.99 (59.16%)	60
SBETSharpLink Gaming Inc	$ 10.54 (-67.60%)	3.63M
AIHSSenmiao Technology Ltd	$ 0.5999 (-41.76%)	4.68M
GNLNGreenlane Holdings Inc	$ 0.0119 (-22.73%)	116.74M
HCTIHealthcare Triangle Inc	$ 0.0241 (-19.67%)	149.68M
RNTXRein Therapeutics Inc	$ 1.60 (-18.78%)	202
HCTIHealthcare Triangle Inc	$ 0.0241 (-19.67%)	149.68M
CGBSCrown LNG Holdings Ltd	$ 0.12035 (43.27%)	145.21M
GNLNGreenlane Holdings Inc	$ 0.0119 (-22.73%)	116.74M
USEGUS Energy Corp	$ 2.46 (73.24%)	43.42M
ICONIcon Energy Corporation	$ 2.91 (62.57%)	20.36M

Symbol

Price

Vol.